Furazabol (CAS 1239-29-8) Suppliers and Product Information

Furazabol is a synthetic, orally active anabolic-androgenic steroid. It is a 17α-alkylated derivative of dihydro*** (DHT) and is structurally similar to stanozolol. The compound has been marketed in Japan since 1969 under brand names such as Frazalon, Miotalon, and Qu Zhi Shu.

Furazabol has a relatively high ratio of anabolic to androgenic activity. It has been described as having hypocholesterolemic properties, although this claim has been disputed. As with other 17α-alkylated anabolic steroids, it may carry a risk of hepatotoxicity.

Frequently Asked Questions about Furazabol

Q: What is the primary use of Furazabol?

A: Furazabol is an anabolic steroid that has been used for its muscle-building and performance-enhancing properties. It has also been claimed to have hypocholesterolemic effects, although this is disputed.

Q: Is Furazabol legal?

A: Furazabol is a controlled substance in many countries. It is classified as an anabolic steroid and its use without a prescription is generally illegal.

Q: What are the potential side effects of Furazabol?

A: As a 17α-alkylated anabolic steroid, Furazabol may carry a risk of hepatotoxicity (liver damage). It may also have other side effects common to anabolic steroids, such as hormonal imbalances and cardiovascular risks.

Q: How is Furazabol different from other anabolic steroids?

A: Furazabol is structurally similar to stanozolol but differs by having a furazan ring system instead of a pyrazole ring. It is known for having a relatively high ratio of anabolic to androgenic activity.